The degree of mesangial cell binding by circulating IgG and IgG1 in serum samples of patients with LN correlates with disease activity, and thus may complement anti-dsDNA and C3 as biomarkers for disease monitoring. This evidence concerns the gene C3 and lobular neoplasia.